Agilent Technologies (NYSE:A) Releases Q3 2025 Earnings Guidance

Agilent Technologies (NYSE:A - Get Free Report) issued an update on its third quarter 2025 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of 1.350-1.370 for the period. The company issued revenue guidance of $1.6 billion-$1.7 billion. Agilent Technologies also updated its FY 2025 guidance to 5.540-5.610 EPS.

Agilent Technologies Trading Down 1.3%

A traded down $1.45 during trading on Friday, reaching $111.83. The company had a trading volume of 4,751,122 shares, compared to its average volume of 1,929,518. The firm's 50-day simple moving average is $108.44 and its 200 day simple moving average is $126.41. The company has a debt-to-equity ratio of 0.55, a quick ratio of 1.66 and a current ratio of 2.09. The company has a market cap of $31.88 billion, a price-to-earnings ratio of 27.61, a PEG ratio of 3.17 and a beta of 1.27. Agilent Technologies has a 12-month low of $96.43 and a 12-month high of $153.84.

Agilent Technologies (NYSE:A - Get Free Report) last released its quarterly earnings results on Wednesday, May 28th. The medical research company reported $1.31 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.26 by $0.05. Agilent Technologies had a net margin of 17.59% and a return on equity of 25.92%. The business had revenue of $1.67 billion for the quarter, compared to analyst estimates of $1.63 billion. During the same quarter in the previous year, the business earned $1.22 earnings per share. The firm's revenue was up 6.0% compared to the same quarter last year. Equities research analysts anticipate that Agilent Technologies will post 5.58 earnings per share for the current year.

Agilent Technologies Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, July 23rd. Stockholders of record on Tuesday, July 1st will be issued a $0.248 dividend. The ex-dividend date is Tuesday, July 1st. This represents a $0.99 dividend on an annualized basis and a dividend yield of 0.89%. Agilent Technologies's payout ratio is currently 24.44%.

Analyst Ratings Changes

Several research analysts recently weighed in on the company. Barclays dropped their price target on Agilent Technologies from $138.00 to $115.00 and set an "equal weight" rating on the stock in a research report on Thursday, April 10th. Wells Fargo & Company lowered their target price on Agilent Technologies from $155.00 to $135.00 and set an "overweight" rating on the stock in a research note on Thursday, April 17th. UBS Group reduced their price target on shares of Agilent Technologies from $150.00 to $130.00 and set a "neutral" rating for the company in a research report on Thursday. Leerink Partners raised their price target on shares of Agilent Technologies to $135.00 and gave the stock a "buy" rating in a report on Friday. Finally, JPMorgan Chase & Co. lowered their price objective on shares of Agilent Technologies from $160.00 to $155.00 and set an "overweight" rating on the stock in a research report on Thursday. Seven analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus price target of $140.15.

Insider Activity at Agilent Technologies

In related news, Director Daniel K. Podolsky sold 1,819 shares of the firm's stock in a transaction on Monday, March 31st. The shares were sold at an average price of $116.46, for a total value of $211,840.74. Following the transaction, the director now directly owns 35,737 shares in the company, valued at approximately $4,161,931.02. This trade represents a 4.84% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, VP Rodney Gonsalves sold 1,908 shares of the stock in a transaction that occurred on Monday, March 17th. The shares were sold at an average price of $121.98, for a total value of $232,737.84. Following the sale, the vice president now owns 21,786 shares of the company's stock, valued at approximately $2,657,456.28. The trade was a 8.05% decrease in their position. The disclosure for this sale can be found here.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the stock. Geneos Wealth Management Inc. raised its position in shares of Agilent Technologies by 54.8% during the first quarter. Geneos Wealth Management Inc. now owns 599 shares of the medical research company's stock valued at $70,000 after buying an additional 212 shares during the last quarter. Brighton Jones LLC grew its position in Agilent Technologies by 6.1% during the fourth quarter. Brighton Jones LLC now owns 4,663 shares of the medical research company's stock worth $626,000 after buying an additional 270 shares in the last quarter. Acadian Asset Management LLC grew its position in Agilent Technologies by 16.5% during the first quarter. Acadian Asset Management LLC now owns 5,352 shares of the medical research company's stock worth $625,000 after buying an additional 758 shares in the last quarter. Finally, Jones Financial Companies Lllp increased its stake in Agilent Technologies by 15.9% during the first quarter. Jones Financial Companies Lllp now owns 5,610 shares of the medical research company's stock valued at $602,000 after acquiring an additional 769 shares during the period.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.